Sector: Health Care | Focus: Health Care Equipment
HQ: Dublin, Ireland
Financial Risks
STERIS faces legal proceedings, including personal injury lawsuits related to ethylene oxide exposure, potentially leading to significant damages. The company's restructuring plan carries future costs. Market risks include interest rate, currency, and commodity fluctuations, impacting revenues and costs. Uncertainties exist regarding tax treatments and potential increases in tax liabilities. There's a risk that anticipated benefits from acquisitions, divestitures, and restructuring may not materialize as expected.
Financial Upside
STERIS experienced revenue growth of 7.3% in Q2 2025 and 7.7% in the first half of 2025, driven by volume and pricing. The company's restructuring plan is expected to improve profitability. Proceeds from the sale of the Dental segment and CECS business generated significant cash flow. STERIS repurchased shares, and paid dividends. The company's debt-to-capital ratio decreased.
